Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,388 | -6,091 | -10,291 | -12,691 | -8,579 |
| Depreciation Amortization | 178 | 189 | 433 | 553 | 2,778 |
| Accounts receivable | -1,301 | 214 | -239 | -854 | 379 |
| Accounts payable and accrued liabilities | 366 | -101 | -201 | 1,195 | -18 |
| Other Working Capital | 441 | -1,545 | 3,636 | 653 | -1,092 |
| Other Operating Activity | 2,778 | 1,255 | 1,563 | 820 | 1,138 |
| Operating Cash Flow | $-1,926 | $-6,079 | $-5,100 | $-10,324 | $-5,394 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 16,015 | -11,164 |
| PPE Investments | -321 | -60 | 164 | -1,379 | -97 |
| Purchase Of Investment | -15,054 | N/A | 0 | N/A | N/A |
| Purchase Sale Intangibles | -231 | -123 | -177 | -177 | -146 |
| Other Investing Activity | -231 | -123 | -177 | -178 | -146 |
| Investing Cash Flow | $-15,606 | $-183 | $-13 | $14,458 | $-11,406 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 7,309 |
| Debt Repayment | N/A | N/A | -5,027 | -2,129 | -493 |
| Common Stock Issued | 27,301 | 2,463 | 10,633 | 1,320 | 17,035 |
| Other Financing Activity | -233 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $27,068 | $2,463 | $5,607 | $-809 | $23,852 |
| Exchange Rate Effect | -26 | 88 | -32 | 12 | 1 |
| Beginning Cash Position | 9,848 | 13,559 | 13,096 | 9,759 | 2,706 |
| End Cash Position | 19,358 | 9,848 | 13,559 | 13,096 | 9,759 |
| Net Cash Flow | $9,510 | $-3,711 | $463 | $3,337 | $7,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,926 | -6,079 | -5,100 | -10,324 | -5,394 |
| Capital Expenditure | -351 | -89 | -11 | -1,379 | -97 |
| Free Cash Flow | -2,277 | -6,169 | -5,111 | -11,704 | -5,491 |